Recent News

• 11.04.2026 - Harvard Bioscience to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health and Services Forum
• 11.03.2026 - Translational Neuroscience Research: Connecting Neural Activity, Behavior, and Physiology
• 10.27.2026 - Harvard Bioscience Schedules Third Quarter 2026 Earnings Conference Call for November 10, 2026 at 8:00 AM ET
• 10.26.2026 - Download Free ALI MEA™ Protocols for Advanced 3D Neural Tissue & Brain Slice Research
• 10.26.2026 - Patch Clamp and the Rise of Optogenetics: Over Two Decades of Research on HEKA Amplifiers
• 10.14.2026 - The Risks Researchers Rarely Talk About in Buffer Preparation
• 10.09.2026 - Artificial Cerebrospinal Fluid (aCSF): The Real Cost Beyond the Price Tag
• 10.06.2026 - Harvard Bioscience Announces Creation of Scientific Advisory Board
• 09.29.2026 - AcadeMEA™ Single-Well MEA System
• 09.29.2026 - ALI MEA™: Air-Liquid Interface Multielectrode Array for Complex Organoid Maintenance

Recent Filings

• 09.22.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.11.2026 - 8-K Current report
• 08.11.2026 - EX-99.1 EX-99.1
• 08.11.2026 - EX-99.1 EX-99.1
• 08.11.2026 - 8-K Current report
• 06.12.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.11.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.11.2026 - 4 Statement of changes in beneficial ownership of securities